These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1372908)

  • 21. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X.
    Manithody C; Yang L; Rezaie AR
    Biochemistry; 2007 Mar; 46(11):3193-9. PubMed ID: 17323935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.
    Fiore MM; Neuenschwander PF; Morrissey JH
    Blood; 1992 Dec; 80(12):3127-34. PubMed ID: 1467519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.
    Sabharwal AK; Birktoft JJ; Gorka J; Wildgoose P; Petersen LC; Bajaj SP
    J Biol Chem; 1995 Jun; 270(26):15523-30. PubMed ID: 7797546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS; Mackman N; Fan ST; Ruf W
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII.
    Ruf W; Miles DJ; Rehemtulla A; Edgington TS
    J Biol Chem; 1992 Nov; 267(31):22206-10. PubMed ID: 1429572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor.
    Roy S; Hass PE; Bourell JH; Henzel WJ; Vehar GA
    J Biol Chem; 1991 Nov; 266(32):22063-6. PubMed ID: 1939226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa.
    Ruf W; Edgington TS
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8430-4. PubMed ID: 1924302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key ligand interface residues in tissue factor contribute independently to factor VIIa binding.
    Schullek JR; Ruf W; Edgington TS
    J Biol Chem; 1994 Jul; 269(30):19399-403. PubMed ID: 8034706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel soluble tissue factor variant with an altered factor VIIa binding interface.
    Lee GF; Kelley RF
    J Biol Chem; 1998 Feb; 273(7):4149-54. PubMed ID: 9461610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor.
    Dickinson CD; Ruf W
    J Biol Chem; 1997 Aug; 272(32):19875-9. PubMed ID: 9242651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ca2+ binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity.
    Persson E; Olsen OH; Ostergaard A; Nielsen LS
    J Biol Chem; 1997 Aug; 272(32):19919-24. PubMed ID: 9242658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of residue Phe225 in the cofactor-mediated, allosteric regulation of the serine protease coagulation factor VIIa.
    Petrovan RJ; Ruf W
    Biochemistry; 2000 Nov; 39(47):14457-63. PubMed ID: 11087398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1994 Mar; 269(11):8007-13. PubMed ID: 8132522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis.
    Gibbs CS; McCurdy SN; Leung LL; Paborsky LR
    Biochemistry; 1994 Nov; 33(47):14003-10. PubMed ID: 7947809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3.
    Fang CH; Lin TC; Guha A; Nemerson Y; Konigsberg WH
    Thromb Haemost; 1996 Sep; 76(3):361-8. PubMed ID: 8883271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 99 and 170 loop-modified factor VIIa mutants show enhanced catalytic activity without tissue factor.
    Soejima K; Yuguchi M; Mizuguchi J; Tomokiyo K; Nakashima T; Nakagaki T; Iwanaga S
    J Biol Chem; 2002 Dec; 277(50):49027-35. PubMed ID: 12364340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.